share_log

Why ReShape Lifesciences Stock Is Moving Higher Wednesday

Why ReShape Lifesciences Stock Is Moving Higher Wednesday

爲什麼 ReShape Lifesciences 股票週三走高
Benzinga ·  05/29 22:47

ReShape Lifesciences, Inc. (NASDAQ:RSLS) shares are trading higher Wednesday morning following the company's announcement that it received approval for its patent application.

ReShape Lifesciences, Inc.(納斯達克股票代碼:RSLS)週三上午股價走高,此前該公司宣佈其專利申請獲得批准。

What Happened: On Tuesday after the market close ReShape Lifesciences reported that it gained approval from the United States Patent and Trademark Office for its application entitled, "Intragastric Device (For Treating Obesity)."

發生了什麼:週二收盤後,ReShape Lifesciences報告稱,其名爲 “胃內設備(用於治療肥胖)” 的申請獲得了美國專利商標局的批准。

In the patent filings, the company described the product as a swallowable implant that expands via a balloon in the stomach to induce a feeling of fullness, helping to restrict food intake.

在專利申請中,該公司將該產品描述爲一種可吞嚥的植入物,它通過氣球在胃中膨脹,產生飽腹感,有助於限制食物攝入。

After a set amount of time, it shrinks back to a smaller size so it can pass through the rest of the digestive system. Furthermore, the product includes visualization and tracking components.

經過一定的時間後,它會縮小到較小的尺寸,這樣它就可以穿過消化系統的其餘部分。此外,該產品還包括可視化和跟蹤組件。

ReShape Lifesciences is currently trending across social media platforms, trading on abnormally high volume following the patent approval. ReShape's average session volume is about 1.6 million, according to Benzinga Pro. Wednesday's trading volume has already exceeded 157 million at publication time.

ReShape Lifesciences目前在社交媒體平台上很流行,專利批准後的交易量異常高。根據Benzinga Pro的數據,ReShape的平均會話量約爲160萬次。截至發佈時,週三的交易量已經超過1.57億。

Related Link: Weight-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up Supply

相關鏈接:隨着諾和諾德和禮來增加供應,減肥藥物的預測飆升至1500億美元

How To Buy RSLS Stock

如何購買 RSLS 股票

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

除了前往經紀平台購買股票的股票(或部分股票)外,您還可以通過購買本身持有股票的交易所交易基金(ETF)來獲得股票,或者將自己分配到401(k)中尋求收購共同基金或其他工具股票的策略。

For example, in Reshape Lifesciences' case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

例如,就重塑生命科學而言,它屬於醫療保健領域。ETF可能會持有許多有助於追蹤該行業的流動性和大型公司的股票,從而使投資者能夠了解該細分市場的趨勢。

RSLS Price Action: According to Benzinga Pro, Reshape Lifesciences stock is trading 61.8% higher at 33 cents at the time of writing.

RSLS價格走勢:根據Benzinga Pro的數據,在撰寫本文時,Reshape Lifesciences的股票交易價格上漲61.8%,至33美分。

Image: 4092613 from Pixabay.

圖片:來自 Pixabay 的 4092613。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論